UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Targeting the fibroblast growth factor receptor family in cancer

Cancer treatment reviews, 2016-05, Vol.46, p.51-62

2016

Link zum Volltext

Verfügbarkeit prüfen

Thymidine Phosphorylase in Cancer; Enemy or Friend?

Cancer microenvironment, 2016-04, Vol.9 (1), p.33-43

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

Journal of translational medicine, 2021-05, Vol.19 (1), p.184-184, Article 184

2021

Link zum Volltext

Verfügbarkeit prüfen

Protein Tyrosine Phosphatase Non-Receptor 11 ( PTPN11 /Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10545

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

Journal of translational medicine, 2020-02, Vol.18 (1), p.99-99, Article 99

2020

Link zum Volltext

Verfügbarkeit prüfen

ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer

Oncology and therapy, 2022-06, Vol.10 (1), p.13-22

2022

Link zum Volltext

Verfügbarkeit prüfen

A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S31-S31

2021

Link zum Volltext

Verfügbarkeit prüfen

Protein Tyrosine Phosphatase Non-Receptor 11

International journal of molecular sciences, 2023-06, Vol.24 (13)

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune Effects of Bevacizumab: Killing Two Birds with One Stone

Cancer microenvironment, 2015-04, Vol.8 (1), p.15-21

2015

Link zum Volltext

Verfügbarkeit prüfen

Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S46

2022

Link zum Volltext

Verfügbarkeit prüfen

97 - Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S46-S46

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3810-3810

2020

Link zum Volltext

Verfügbarkeit prüfen

Body Fatness and Cancer

The New England journal of medicine, 2016-11, Vol.375 (20), p.2007-2008

2016

Link zum Volltext

Verfügbarkeit prüfen

Correlation of the SOX9 FGFR2b feed forward loop with prognostic variants and survival in resected pancreatic cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15282-e15282

2015

Link zum Volltext

Verfügbarkeit prüfen

P2.01-066 PD-L1 Tumor Expression and Its Effect on Overall Survival among Patients with Resected Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S827

2017

Link zum Volltext

Verfügbarkeit prüfen

P2.01-066 PD-L1 Tumor Expression and Its Effect on Overall Survival among Patients with Resected Non-Small Cell Lung Cancer (NSCLC): Topic: Immune Mechanisms in Thoracic Cancer and Targeted Therapy

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S827-S827

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact and correlation of mutational load (ML) and specific mutations (mts) assessed by limited targeted profiling (LTP) with PD-L1 tumour expression (exp) in resected non-small cell lung carcinoma (NSCLC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11587-11587

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6463: Persistence of smoking mutational signatures in the non-small cell lung cancer genome

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6463-6463

2023

Link zum Volltext

Verfügbarkeit prüfen

Protein tyrosine phosphatase non receptor 11 ( PTPN11 /Shp2) as a driver oncogene and a novel therapeutic target in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11077-11077

2015

Link zum Volltext

Verfügbarkeit prüfen

The role of protein tyrosine phosphatase non-receptor 11 ( PTPN11 ) mutations in lung squamous cell carcinoma (SQCC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e22174-e22174

2014

Link zum Volltext

Verfügbarkeit prüfen

Identifying driver mutations in squamous cell lung cancer (SCC): The Lung Cancer Genomics Ireland (LCGI) study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11078-11078

2015

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement

Tumori, 2015-03, Vol.101 (2), p.e35-e39

2015

Link zum Volltext

Verfügbarkeit prüfen

Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience

European archives of oto-rhino-laryngology, 2014-08, Vol.271 (8), p.2253-2259

2014

Link zum Volltext

Verfügbarkeit prüfen

A rare case of nasopharyngeal carcinoma with widespread CNS metastases

Irish medical journal, 2014-06, Vol.107 (6), p.180-181

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(7)
Cancer
(5)
Oncology
(5)
Antineoplastic Agents - Therapeutic Use
(4)
Metastasis
(4)
Cancer Research
(3)
Genetic Aspects
(3)
Kinases
(3)
Mutation
(3)
Proteins
(3)
Signal Transduction
(3)
Tumors
(3)
1-Phosphatidylinositol 3-Kinase
(2)
Adult
(2)
Biochemistry
(2)
Biomedical And Life Sciences
(2)
Biomedicine
(2)
Cancer Therapies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting the fibroblast growth factor receptor family in cancer

Thymidine Phosphorylase in Cancer; Enemy or Friend?

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

Protein Tyrosine Phosphatase Non-Receptor 11 ( PTPN11 /Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer

A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic

Protein Tyrosine Phosphatase Non-Receptor 11

Immune Effects of Bevacizumab: Killing Two Birds with One Stone

Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

97 - Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome

Body Fatness and Cancer

Correlation of the SOX9 FGFR2b feed forward loop with prognostic variants and survival in resected pancreatic cancer

P2.01-066 PD-L1 Tumor Expression and Its Effect on Overall Survival among Patients with Resected Non-Small Cell Lung Cancer (NSCLC)

P2.01-066 PD-L1 Tumor Expression and Its Effect on Overall Survival among Patients with Resected Non-Small Cell Lung Cancer (NSCLC): Topic: Immune Mechanisms in Thoracic Cancer and Targeted Therapy

Impact and correlation of mutational load (ML) and specific mutations (mts) assessed by limited targeted profiling (LTP) with PD-L1 tumour expression (exp) in resected non-small cell lung carcinoma (NSCLC)

Abstract 6463: Persistence of smoking mutational signatures in the non-small cell lung cancer genome

Protein tyrosine phosphatase non receptor 11 ( PTPN11 /Shp2) as a driver oncogene and a novel therapeutic target in non-small cell lung cancer (NSCLC)

The role of protein tyrosine phosphatase non-receptor 11 ( PTPN11 ) mutations in lung squamous cell carcinoma (SQCC)

Identifying driver mutations in squamous cell lung cancer (SCC): The Lung Cancer Genomics Ireland (LCGI) study

Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement

Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience

A rare case of nasopharyngeal carcinoma with widespread CNS metastases

Suchergebnisse filtern